Fact CheckerSign in

NCT06037902Recruiting

CPAP for Esophageal Cancer With Radiotherapy

Use of CPAP (Continuous Positive Airway Pressure) for Simulating Esophageal Cancer Patients Prior to Radiotherapy

Source: ClinicalTrials.gov · Last updated 14 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to test the use of CPAP in patients with esophgaeal cancer undergoing radiotherapy. The main questions it aims to answer are: * does use of CPAP decrease exposure of normal lung to radiation? * does use of CPAP decrease exposure of normal heart to radiation? Participants will undergo simulation twice: * with CPAP * without CPAP

Status (registry)
Recruiting
Study type
Interventional
Enrollment
44 (estimated)
First submitted
28 Aug 2023
Start date
21 Aug 2023
Primary completion date
30 Sept 2027
Lead sponsor
Sheba Medical Center
NCT number
NCT06037902

What you commit to

  • Study type: Interventional
  • Planned participants: 44
  • From 21 Aug 2023 to the primary completion date, 30 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A history of a psychiatric problem that may impair the patient's ability to understand the research requirements or respond to them, or to give his consent

Other

  • A person who meets any of the following exclusion criteria will not be able to participate in the study:
  • Pregnancy or breastfeeding
  • Significant comorbidity at the starting point that would prevent the use of CPAP
  • Hospitalized in an institution by virtue of an administrative order or a court order.
  • Special population

Who the study is looking for

  • Diagnosis of cancer, with a tumor (primary or secondary) in the esophagus including tumors in the esophagus-stomach junction.
  • Age ≥ 18
  • Planned RT treatment
  • The level of functioning ≥ 60 on the Karnofsky scale
  • Life expectancy ≥ two months
  • All patients must understand the informed consent form document and sign it of their own free will before any test/procedure related to the study is performed.
  • Able to undergo simulation and radiation with CPAP
  • Candidate patients can be recruited to receive definitive, palliative or pre-operative radiation, with or without chemotherapy.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sheba medical center
Coordinator of this site? Confirm its status
Ramat GanIsraelRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.